COTY Coty Inc.
Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products in the United States and internationally. It operates through two segments: Prestige and Consumer Beauty. The company provides fragrances, color cosmetics, and skin and body care products. It offers prestige products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under Burberry, Calvin Klein, Chloe, Davidoff, Escada, Etro, Gucci, Hugo Boss, Infiniment Coty Paris, Jil Sander, Joop!, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Orveda, philosophy, and Tiffany & Co. brands. The company provides beauty products through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, David Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, LeGer by Lena Gercke, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Vera Wang, and Sally Hansen brands. It also sells its products through third-party distributors. Coty Inc. was founded in 1904 and is headquartered in New York, New York. Coty Inc. operates as a subsidiary of JAB Beauty B.V.…
Industry Peers
Household & Personal ProductsKey Statistics
About Coty (NYSE: COTY)
›
Coty (NYSE: COTY) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Household & Personal Products industry, part of the Consumer Defensive sector, and reports about 11,335 employees.
The shares were at 3.950 USD on 20 November 2026, up 17.9% over 52 weeks. Its 52-week range is 1.820 USD to 4.365 USD: the price is 9.5% below the high and 117.0% above the low.
Its market capitalisation is 3.48B USD.
Coty reports return on equity of -19.3%, an operating margin of 5.2% and revenue down 1.4% year over year.
Its debt exceeds its cash by 2.79B USD, a debt-to-equity ratio of 1.05. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Hold; their mean price target of 3.410 USD is 13.7% below the current price. The next earnings report is expected on 4 February 2027.